Navigation Links
Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy
Date:6/16/2009

Tampa, Fla. (June 16, 2009) To determine if guided fat (adipose) precursor cells (APCs) could improve nerve regeneration and functional recovery, researchers at the University of Pittsburgh (USA) used biodegradable nerve guides to transplant APCs into the injured peripheral nerves of laboratory rats.

"Adipose tissues, shown to be multipotent, have also been shown to be an abundant source of post-natal precursor cells that are relatively easy to isolate from fat tissue and in sufficient amounts to be injected immediately post-isolation," said Dr. Kacey Marra, lead author of a study published in the current issue of the journal Cell Transplantation (18:2).

Adipose precursor cells, said Marra and co-authors, have demonstrated an ability to differentiate in vitro into cartilage (chondrogenic), bone (osteogenic), fat (adipogenic) and muscle (myogenic) cell types.

Control groups for this study included those with no treatment, those receiving an autograft but no nerve guide tube, and those receiving an autograft and nerve guide tube but no APC transplant in the guide tube.

Researchers noted that the "gold standard" for nerve repair is the autograft to repair nerve gaps. Pre-clinical studies have shown that including Schwann cells within nerve conduits can enhance nerve regeneration. However, the incorporation of Schwann cells requires a second surgery, renders a secondary nerve nonfunctional, and requires Schwann cells in high numbers that are clinically challenging to obtain.

According to the researchers, significant differences in the sciatic functional index (SFI) were observed three weeks post-injury in the autografted, APC-transplanted group using nerve guides over a control group in which nerve guides were left empty. Researchers also observed the formation of a more robust nerve accompanied by modestly decreased muscle atrophy in the APC-transplanted group. No differences were observed after 12 weeks, however.

"We found that full regeneration of the sciatic nerve occurred in the rats receiving the autograft, the guide, and the guide loaded with APCs. No regeneration was observed in any of the rats in which the defect was left untreated," said Marra.

Their results also showed that transplanted human-derived APCs survived for up to 12 weeks in the injured peripheral nerve and formed a more robust nerve with nerve cells more than double the size of those formed using the conduit alone.

"The versatility of adult precursor cells, such as those from adipose, for the treatment of a number of disorders is promising and this study demonstrates their potential benefit towards nerve repair," said section editor Dr. John Sladek, professor of pediatrics and neuroscience at the University of Colorado School of Medicine.


'/>"/>

Contact: Anita Srikameswaran
412-647-3555
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Seeing stem cells helps in fight against peripheral arterial disease
2. At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better
3. Engineer develops detergent to promote peripheral nerve healing
4. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
5. Long-lasting nerve block could change pain management
6. Spun-sugar fibers spawn sweet technique for nerve repair
7. Motor nerve targeting to limb muscles is controlled by ephrin proteins
8. Shared survival mechanism explains why good nerve cells last and bad cancer cells flourish
9. UC Davis team refines cancer treatments to reduce potential nerve damage
10. Prostate cancer spurs new nerves
11. Mammals can be stimulated to regrow damaged inner retina nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a ... its financial results for the fourth quarter and fiscal year ... Total sales in the fourth quarter ... by 13.6% in USD terms to $77.6 million from $68.3 ... Gross profit increased by 13.3% to $46.8 million from $41.3 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
Breaking Biology Technology: